Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

PainReform Ltd. (PRFX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9900+0.0252 (+2.61%)
At close: 03:32PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.9648
Open1.0550
Bid0.9899 x 1200
Ask1.1200 x 1000
Day's Range0.8639 - 1.2878
52 Week Range0.7050 - 7.8400
Volume43,129
Avg. Volume29,317
Market Cap10.377M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.6860
Earnings DateNov 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
  • GlobeNewswire

    PainReform Provides Business Update for the First Quarter of 2022

    Reports successful batch manufacturing of PRF-110 and continued progress towards commencing Phase 3 clinical trials in the second half of 2022TEL AVIV, Israel, May 17, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, yesterday provided a business update for the first quarter ended March 31, 2022. Ilan Hadar, Chief Executive Officer of Pain Reform, st

  • GlobeNewswire

    PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th

    TEL AVIV, Israel, April 12, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform will present at the Noble Capital Markets’ Eighteenth Annual Investor Conference being held on April 20-21, 2022 at the Hard Rock Hotel & Casino in Hollywood, Florida. Mr. Hadar will present on Wednesday, April 20th at 12:00 pm Eastern

  • GlobeNewswire

    PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

    TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced it will present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT. The conference will feature roundtable discussions, fireside chats, and multiple company presentatio

Advertisement
Advertisement